Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Presynaptic Inhibition of Primary Nociceptive Signals to Dorsal Horn Lamina I Neurons by Dopamine.

Lu Y, Doroshenko M, Lauzadis J, Kanjiya MP, Rebecchi MJ, Kaczocha M, Puopolo M.

J Neurosci. 2018 Oct 10;38(41):8809-8821. doi: 10.1523/JNEUROSCI.0323-18.2018. Epub 2018 Aug 24.

PMID:
30143577
2.

SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins.

Yan S, Elmes MW, Tong S, Hu K, Awwa M, Teng GYH, Jing Y, Freitag M, Gan Q, Clement T, Wei L, Sweeney JM, Joseph OM, Che J, Carbonetti GS, Wang L, Bogdan DM, Falcone J, Smietalo N, Zhou Y, Ralph B, Hsu HC, Li H, Rizzo RC, Deutsch DG, Kaczocha M, Ojima I.

Eur J Med Chem. 2018 Jun 25;154:233-252. doi: 10.1016/j.ejmech.2018.04.050. Epub 2018 May 26.

PMID:
29803996
3.

Lipocalin-Type Prostaglandin D Synthase Is a Novel Phytocannabinoid-Binding Protein.

Elmes MW, Volpe AD, d'Oelsnitz S, Sweeney JM, Kaczocha M.

Lipids. 2018 Mar;53(3):353-360. doi: 10.1002/lipd.12035. Epub 2018 Apr 18.

PMID:
29668081
4.

Fatty acid-binding proteins 5 and 7 gene deletion increases sucrose consumption and diminishes forced swim immobility time.

Hamilton J, Koumas C, Clavin BH, Marion M, Figueiredo A, Gonzalez S, O'Rourke JR, Deutsch D, Kaczocha M, Haj-Dahmane S, Thanos PK.

Behav Pharmacol. 2018 Sep;29(6):503-508. doi: 10.1097/FBP.0000000000000402.

PMID:
29570114
5.

Contribution of diacylglycerol lipase β to pain after surgery.

Luk J, Lu Y, Ackermann A, Peng X, Bogdan D, Puopolo M, Komatsu DE, Tong S, Ojima I, Rebecchi MJ, Kaczocha M.

J Pain Res. 2018 Mar 5;11:473-482. doi: 10.2147/JPR.S157208. eCollection 2018.

6.

Fatty-acid-binding protein 5 controls retrograde endocannabinoid signaling at central glutamate synapses.

Haj-Dahmane S, Shen RY, Elmes MW, Studholme K, Kanjiya MP, Bogdan D, Thanos PK, Miyauchi JT, Tsirka SE, Deutsch DG, Kaczocha M.

Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):3482-3487. doi: 10.1073/pnas.1721339115. Epub 2018 Mar 12.

7.

Intrathecal morphine administration reduces postoperative pain and peripheral endocannabinoid levels in total knee arthroplasty patients: a randomized clinical trial.

Kaczocha M, Azim S, Nicholson J, Rebecchi MJ, Lu Y, Feng T, Romeiser JL, Reinsel R, Rizwan S, Shodhan S, Volkow ND, Benveniste H.

BMC Anesthesiol. 2018 Feb 27;18(1):27. doi: 10.1186/s12871-018-0489-5.

8.

Fatty acid binding protein deletion prevents stress-induced preference for cocaine and dampens stress-induced corticosterone levels.

Hamilton J, Marion M, Figueiredo A, Clavin BH, Deutsch D, Kaczocha M, Haj-Dahmane S, Thanos PK.

Synapse. 2018 Jun;72(6):e22031. doi: 10.1002/syn.22031. Epub 2018 Feb 19.

9.

Fatty acid-binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation.

Bogdan D, Falcone J, Kanjiya MP, Park SH, Carbonetti G, Studholme K, Gomez M, Lu Y, Elmes MW, Smietalo N, Yan S, Ojima I, Puopolo M, Kaczocha M.

J Biol Chem. 2018 Apr 6;293(14):5295-5306. doi: 10.1074/jbc.RA118.001593. Epub 2018 Feb 13.

PMID:
29440395
10.

Pharmacological Inhibition of Brain Fatty Acid Binding Protein Reduces Ethanol Consumption in Mice.

Figueiredo A, Hamilton J, Marion M, Blum K, Kaczocha M, Haj-Dahmane S, Deutsch D, Thanos PK.

J Reward Defic Syndr Addict Sci. 2017;3(2):21-27. Epub 2017 Oct 31.

11.

Interleukin-6 and leptin levels are associated with preoperative pain severity in patients with osteoarthritis but not with acute pain after total knee arthroplasty.

Azim S, Nicholson J, Rebecchi MJ, Galbavy W, Feng T, Rizwan S, Reinsel RA, Kaczocha M, Benveniste H.

Knee. 2018 Jan;25(1):25-33. doi: 10.1016/j.knee.2017.12.001. Epub 2018 Jan 8.

PMID:
29325836
12.

The Antinociceptive Agent SBFI-26 Binds to Anandamide Transporters FABP5 and FABP7 at Two Different Sites.

Hsu HC, Tong S, Zhou Y, Elmes MW, Yan S, Kaczocha M, Deutsch DG, Rizzo RC, Ojima I, Li H.

Biochemistry. 2017 Jul 11;56(27):3454-3462. doi: 10.1021/acs.biochem.7b00194. Epub 2017 Jun 28.

13.

Transcriptomic evidence of a para-inflammatory state in the middle aged lumbar spinal cord.

Galbavy W, Lu Y, Kaczocha M, Puopolo M, Liu L, Rebecchi MJ.

Immun Ageing. 2017 Apr 13;14:9. doi: 10.1186/s12979-017-0091-6. eCollection 2017.

14.

Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and central mechanisms.

Peng X, Studholme K, Kanjiya MP, Luk J, Bogdan D, Elmes MW, Carbonetti G, Tong S, Gary Teng YH, Rizzo RC, Li H, Deutsch DG, Ojima I, Rebecchi MJ, Puopolo M, Kaczocha M.

Mol Pain. 2017 Jan;13:1744806917697007. doi: 10.1177/1744806917697007.

15.

Presynaptic inhibition of transient receptor potential vanilloid type 1 (TRPV1) receptors by noradrenaline in nociceptive neurons.

Chakraborty S, Elvezio V, Kaczocha M, Rebecchi M, Puopolo M.

J Physiol. 2017 Apr 15;595(8):2639-2660. doi: 10.1113/JP273455. Epub 2017 Feb 22.

16.

Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels.

Martin GG, Chung S, Landrock D, Landrock KK, Dangott LJ, Peng X, Kaczocha M, Murphy EJ, Kier AB, Schroeder F.

Lipids. 2016 Sep;51(9):1007-20. doi: 10.1007/s11745-016-4175-4. Epub 2016 Jul 23.

17.

FABP-1 gene ablation impacts brain endocannabinoid system in male mice.

Martin GG, Chung S, Landrock D, Landrock KK, Huang H, Dangott LJ, Peng X, Kaczocha M, Seeger DR, Murphy EJ, Golovko MY, Kier AB, Schroeder F.

J Neurochem. 2016 Aug;138(3):407-22. doi: 10.1111/jnc.13664. Epub 2016 Jun 22.

18.

Fatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.

Schroeder F, McIntosh AL, Martin GG, Huang H, Landrock D, Chung S, Landrock KK, Dangott LJ, Li S, Kaczocha M, Murphy EJ, Atshaves BP, Kier AB.

Lipids. 2016 Jun;51(6):655-76. doi: 10.1007/s11745-016-4155-8. Epub 2016 Apr 27. Review.

19.

Examination of the Addictive and Behavioral Properties of Fatty Acid-Binding Protein Inhibitor SBFI26.

Thanos PK, Clavin BH, Hamilton J, O'Rourke JR, Maher T, Koumas C, Miao E, Lankop J, Elhage A, Haj-Dahmane S, Deutsch D, Kaczocha M.

Front Psychiatry. 2016 Apr 5;7:54. doi: 10.3389/fpsyt.2016.00054. eCollection 2016.

20.

Dopamine modulation of transient receptor potential vanilloid type 1 (TRPV1) receptor in dorsal root ganglia neurons.

Chakraborty S, Rebecchi M, Kaczocha M, Puopolo M.

J Physiol. 2016 Mar 15;594(6):1627-42. doi: 10.1113/JP271198. Epub 2016 Jan 6.

21.

Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms.

Kaczocha M, Glaser ST, Maher T, Clavin B, Hamilton J, O'Rourke J, Rebecchi M, Puopolo M, Owada Y, Thanos PK.

Mol Pain. 2015 Aug 28;11:52. doi: 10.1186/s12990-015-0056-8.

22.

Neuroimmune and Neuropathic Responses of Spinal Cord and Dorsal Root Ganglia in Middle Age.

Galbavy W, Kaczocha M, Puopolo M, Liu L, Rebecchi MJ.

PLoS One. 2015 Aug 4;10(8):e0134394. doi: 10.1371/journal.pone.0134394. eCollection 2015.

23.

Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms.

Sirrs S, van Karnebeek CD, Peng X, Shyr C, Tarailo-Graovac M, Mandal R, Testa D, Dubin D, Carbonetti G, Glynn SE, Sayson B, Robinson WP, Han B, Wishart D, Ross CJ, Wasserman WW, Hurwitz TA, Sinclair G, Kaczocha M.

Orphanet J Rare Dis. 2015 Mar 28;10:38. doi: 10.1186/s13023-015-0248-3.

24.

Leptin levels are negatively correlated with 2-arachidonoylglycerol in the cerebrospinal fluid of patients with osteoarthritis.

Nicholson J, Azim S, Rebecchi MJ, Galbavy W, Feng T, Reinsel R, Rizwan S, Fowler CJ, Benveniste H, Kaczocha M.

PLoS One. 2015 Apr 2;10(4):e0123132. doi: 10.1371/journal.pone.0123132. eCollection 2015.

25.

Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).

Elmes MW, Kaczocha M, Berger WT, Leung K, Ralph BP, Wang L, Sweeney JM, Miyauchi JT, Tsirka SE, Ojima I, Deutsch DG.

J Biol Chem. 2015 Apr 3;290(14):8711-21. doi: 10.1074/jbc.M114.618447. Epub 2015 Feb 9.

26.

Endocannabinoids and acute pain after total knee arthroplasty.

Azim S, Nicholson J, Rebecchi MJ, Galbavy W, Feng T, Reinsel R, Volkow ND, Benveniste H, Kaczocha M.

Pain. 2015 Feb;156(2):341-347. doi: 10.1097/01.j.pain.0000460315.80981.59.

27.

Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia.

Kaczocha M, Rebecchi MJ, Ralph BP, Teng YH, Berger WT, Galbavy W, Elmes MW, Glaser ST, Wang L, Rizzo RC, Deutsch DG, Ojima I.

PLoS One. 2014 Apr 4;9(4):e94200. doi: 10.1371/journal.pone.0094200. eCollection 2014.

28.

Crystallographic study of FABP5 as an intracellular endocannabinoid transporter.

Sanson B, Wang T, Sun J, Wang L, Kaczocha M, Ojima I, Deutsch D, Li H.

Acta Crystallogr D Biol Crystallogr. 2014 Feb;70(Pt 2):290-8. doi: 10.1107/S1399004713026795. Epub 2014 Jan 29.

29.

Role of FAAH-like anandamide transporter in anandamide inactivation.

Leung K, Elmes MW, Glaser ST, Deutsch DG, Kaczocha M.

PLoS One. 2013 Nov 4;8(11):e79355. doi: 10.1371/journal.pone.0079355. eCollection 2013.

30.

Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs.

Berger WT, Ralph BP, Kaczocha M, Sun J, Balius TE, Rizzo RC, Haj-Dahmane S, Ojima I, Deutsch DG.

PLoS One. 2012;7(12):e50968. doi: 10.1371/journal.pone.0050968. Epub 2012 Dec 7.

31.

Anandamide externally added to lipid vesicles containing trapped fatty acid amide hydrolase (FAAH) is readily hydrolyzed in a sterol-modulated fashion.

Kaczocha M, Lin Q, Nelson LD, McKinney MK, Cravatt BF, London E, Deutsch DG.

ACS Chem Neurosci. 2012 May 16;3(5):364-8. doi: 10.1021/cn300001w. Epub 2012 Jan 18.

32.

Fatty acid-binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors.

Kaczocha M, Vivieca S, Sun J, Glaser ST, Deutsch DG.

J Biol Chem. 2012 Jan 27;287(5):3415-24. doi: 10.1074/jbc.M111.304907. Epub 2011 Dec 14.

33.

Cyclooxygenase-2 mediates anandamide metabolism in the mouse brain.

Glaser ST, Kaczocha M.

J Pharmacol Exp Ther. 2010 Nov;335(2):380-8. doi: 10.1124/jpet.110.168831. Epub 2010 Aug 11.

34.

Lipid droplets are novel sites of N-acylethanolamine inactivation by fatty acid amide hydrolase-2.

Kaczocha M, Glaser ST, Chae J, Brown DA, Deutsch DG.

J Biol Chem. 2010 Jan 22;285(4):2796-806. doi: 10.1074/jbc.M109.058461. Epub 2009 Nov 19.

35.

Temporal changes in mouse brain fatty acid amide hydrolase activity.

Glaser ST, Kaczocha M.

Neuroscience. 2009 Oct 6;163(2):594-600. doi: 10.1016/j.neuroscience.2009.06.043. Epub 2009 Jun 23.

36.

Identification of intracellular carriers for the endocannabinoid anandamide.

Kaczocha M, Glaser ST, Deutsch DG.

Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6375-80. doi: 10.1073/pnas.0901515106. Epub 2009 Mar 23.

37.

2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook.

Hermann A, Kaczocha M, Deutsch DG.

AAPS J. 2006;8(2):E409-12. Review.

38.

Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase.

Kaczocha M, Hermann A, Glaser ST, Bojesen IN, Deutsch DG.

J Biol Chem. 2006 Apr 7;281(14):9066-75. Epub 2006 Feb 6.

39.

Anandamide transport: a critical review.

Glaser ST, Kaczocha M, Deutsch DG.

Life Sci. 2005 Aug 19;77(14):1584-604. Review.

PMID:
15979096
40.

Evidence against the presence of an anandamide transporter.

Glaser ST, Abumrad NA, Fatade F, Kaczocha M, Studholme KM, Deutsch DG.

Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4269-74. Epub 2003 Mar 24.

Supplemental Content

Loading ...
Support Center